EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model

Barkha J Yadav-Samudrala iD, Morgan L Johnson, Ashima Ale, Katherine Xiaofan Jiang, William W Y Lee, Amy Nguyen, Dorian Ho, Essie B Acquah iD, Isabella C Orsucci, Laith E Sawaqed, Gabriella Boyer, Justin L Poklis und 2 weitere

PLOS One · 20.07.2026 · 21 (7) · e0353267

DOI: 10.1371/journal.pone.0353267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 20.07.2026. Verfasst von Barkha J Yadav-Samudrala und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America. Hauptthemen laut MEDLINE: Endocannabinoids, Signal Transduction, Cannabidiol, tat Gene Products, Human Immunodeficiency Virus. Die Arbeit nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As the population of older individuals living with HIV continues to expand, identifying non-euphoric therapeutic interventions for HIV-associated complications is essential. While cannabidiol (CBD) has demonstrated neuroprotective potential, its effects following prolonged exposure in the context of an aging biological environment remain poorly understood. This study utilized aged (15–18 months) male and female HIV-1 Tat transgenic mice to evaluate the impact of chronic CBD (3 mg/kg, s.c., for 12 weeks). A behavioral battery was employed to assess object recognition memory, anxiety-like behavior, spontaneous nociception, and locomotor activity. Subsequently, liquid chromatography-tandem mass spectrometry and Western blotting were used to map endocannabinoid ligands (AEA, 2-AG, AA), metabolic enzymes (FAAH, MAGL), and receptors (CB 1 R, CB 2 R, GPR55) across the prefrontal cortex, amygdala, brainstem, and spinal cord. Results indicated that chronic CBD improved recognition memory specifically in female Tat(+) mice. While CBD treatment did not affect spinal cord-related tail flick sensitivity it universally increased supraspinal hot plate sensitivity. Chronic CBD treatment also elevated baseline body temperature and modulated body mass without impairing general locomotion. Furthermore, chronic CBD restructured the eCB signaling landscape across all examined CNS regions in a highly sex- and genotype-dependent manner. Notably, cannabinoid receptor and GPR55 expression exhibited distinct regulatory shifts governed by significant three-way interactions. These findings demonstrate that chronic CBD intervention interacts with the eCB system of aged mice in a region-specific manner. These results underscore the critical importance of considering age, sex, and treatment duration when evaluating cannabinoid-based therapies for the management of neuroHIV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsSignal TransductionCannabidioltat Gene Products, Human Immunodeficiency VirusBehavior, AnimalAgingHIV-1AnimalsMice, TransgenicFemaleMaleMiceDisease Models, AnimalHumansMemory

Substanzen

EndocannabinoidsCannabidioltat Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
  • Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, Virginia, United States of America.
  • Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, South Carolina, United States of America.
  • Division of Infectious Diseases, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, United States of America.

ORCID-Profile: Barkha J Yadav-Samudrala, Essie B Acquah

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Yadav-Samudrala, B. J., Johnson, M. L., Ale, A., Jiang, K. X., Lee, W. W. Y., Nguyen, A., Ho, D., Acquah, E. B., Orsucci, I. C., Sawaqed, L. E., Boyer, G., Poklis, J. L., Jiang, W., & Fitting, S. (2026). Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model. PLOS One, 21(7), e0353267. https://doi.org/10.1371/journal.pone.0353267

Vancouver

Yadav-Samudrala BJ, Johnson ML, Ale A, Jiang KX, Lee WWY, Nguyen A, et al. Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model. PLOS One. 2026;21(7):e0353267. doi:10.1371/journal.pone.0353267

BibTeX
@article{YadavSamudrala2026,
  author = {Yadav-Samudrala, Barkha J and Johnson, Morgan L and Ale, Ashima and Jiang, Katherine Xiaofan and Lee, William W Y and Nguyen, Amy and Ho, Dorian and Acquah, Essie B and Orsucci, Isabella C and Sawaqed, Laith E and Boyer, Gabriella and Poklis, Justin L and Jiang, Wei and Fitting, Sylvia},
  title = {Chronic CBD treatment differentially modulates neurobehavioral outcomes and endocannabinoid signaling in an aged HIV-1 Tat transgenic mouse model},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0353267},
  doi = {10.1371/journal.pone.0353267}
}
Kostenlos starten →